Hamilton Lane (NASDAQ:HLNE) had its price target raised by analysts at Keefe, Bruyette & Woods from $158.00 to $161.00. They now have an "outperform" rating on the stock.
Anchorage Digital Acquires Securitize Platform in Major Crypto Wealth Management Consolidation [Yahoo! Finance]
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic suspension), with 180 days Competitive Generic Therapy (CGT) exclusivity
Slate Asset Management and Hamilton Lane Acquire Majority Stake in Cold-Link Logistics, a Leading North American Cold Storage Platform
Hamilton Lane (NASDAQ:HLNE) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.